C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy | Zendy

Rishi Puri | Zendy; Steven E. Nissen | Zendy; Peter Libby | Zendy; Mingyuan Shao | Zendy; Christie M. Ballantyne | Zendy; P.J. Barter | Zendy; M. John Chapman | Zendy; Raimund Erbel | Zendy; Joel S. Raichlen | Zendy; Kiyoko Uno | Zendy; Yu Kataoka | Zendy; Stephen J. Nicholls | Zendy

Open Access

C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy

Author(s) -

Rishi Puri,

Steven E. Nissen,

Peter Libby,

Mingyuan Shao,

Christie M. Ballantyne,

P.J. Barter,

M. John Chapman,

Raimund Erbel,

Joel S. Raichlen,

Kiyoko Uno,

Yu Kataoka,

Stephen J. Nicholls

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.004243

Subject(s) - medicine , mace , rosuvastatin , cardiology , atheroma , intravascular ultrasound , hazard ratio , c reactive protein , myocardial infarction , atorvastatin , confidence interval , unstable angina , percutaneous coronary intervention , inflammation

Baseline C-reactive protein (CRP) levels predict major adverse cardiovascular events (MACE: death, myocardial infarction, stroke, coronary revascularization, and hospitalization for unstable angina). The association between changes in CRP levels with plaque progression and MACE in the setting of maximally intensive statin therapy is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research